Vertebrate female reproduction is limited by the oocyte stockpiles acquired during embryonic development. These are gradually depleted over the organism's lifetime through the process of apoptosis. The timer that triggers this cell death is yet to be identified. We used the Xenopus egg/oocyte system to examine the hypothesis that nutrient stores can regulate oocyte viability. We show that pentose-phosphate-pathway generation of NADPH is critical for oocyte survival and that the target of this regulation is caspase-2, previously shown to be required for oocyte death in mice. Pentose-phosphate-pathway-mediated inhibition of cell death was due to the inhibitory phosphorylation of caspase-2 by calcium/calmodulin-dependent protein kinase II (CaMKII). These data suggest that exhaustion of oocyte nutrients, resulting in an inability to generate NADPH, may contribute to ooctye apoptosis. These data also provide unexpected links between oocyte metabolism, CaMKII, and caspase-2.
Introduction
Vertebrate female reproduction is limited by the oocyte stockpiles acquired during embryonic development. Apoptotic loss of oocytes over a lifetime leads ultimately to loss of fertility (Tilly, 2001 ). In addition, pathological insults or chemotherapeutic treatment can accelerate oocyte death, resulting in premature oocyte depletion and sterility (Perez et al., 1997) . Despite the importance of oocyte survival in determining female fertility, the molecular pathways governing the timing of apoptosis in these cells are not fully understood.
Genetic analyses in mice and in vitro experiments using murine oocytes have provided a framework in which to understand the molecular underpinnings of oocyte apoptosis. Death of these cells can be prevented by caspase inhibitors or antiapoptotic Bcl-2 proteins and induced by overexpression of either caspases or proapoptotic Bcl-2 family members ( Insight into oocyte apoptosis has come from studies of knockout mice deficient in caspase-2. Surprisingly, these mice developed normally, with one striking exception: female mice were endowed with an excess of oocytes. Moreover, caspase-2-deficient oocytes were markedly resistant to cell death induced by chemotherapeutics (Bergeron et al., 1998 ). The precise role of caspase-2 in cell death has been controversial, but recent studies demonstrate that it can act upstream of the mitochondria in a number of settings to trigger cytochrome c release (Guo et Although genetic analyses and microinjection studies have provided critical information for understanding oocyte apoptosis, most vertebrate oocytes are not amenable to biochemical analysis due to their small size and limited abundance. However, over a decade ago, Newmeyer et al. reported that extracts prepared from eggs of the frog, Xenopus laevis, could, upon prolonged incubation at room temperature, spontaneously recapitulate many events of apoptosis, including mitochondrial cytochrome c release, caspase activation, and nuclear fragmentation (Newmeyer et al., 1994) . Importantly, this in vitro apoptosis could be inhibited by antiapoptotic Bcl-2 proteins and caspase inhibitors, suggesting that at least some aspects of germ-cell apoptosis are faithfully recapitulated in this system, thereby providing a biochemically manipulable setting in which to understand germ-cell apoptosis (Kluck et al., 1997) .
Despite the ease of manipulation of Xenopus eggs and oocytes and the manifestation of apoptotic markers, it was not clear what might be driving apoptosis in this system. Although initial reports suggested that the timing of hormone administration used to elicit egg laying might determine the susceptibility of eggs to apoptosis, research in the intervening years has failed to establish a firm correlation between the rates of apoptosis in Xenopus eggs and the hormonal regimen used to obtain the eggs. Hence, we were driven to consider other features of the oocyte/egg that might contribute to cell-death regulation. In this regard, we were interested in the fact that oocytes are uniquely endowed with a large stockpile of nutrients in the form of both yolk proteins and glycogen stores, which are used to sustain early embryonic development.
Numerous Here, using the facile biochemistry provided by the Xenopus system, we report the identification and characterization of a novel caspase-2 regulatory pathway responsive to the metabolic state of the oocyte/egg. We demonstrate that glucose-6-phosphate (G6P) sufficient to drive continual operation of the pentose phosphate pathway can greatly prolong germ-cell survival. Moreover, our data indicate that NADPH generation by this pathway is critical for promoting survival and that a surfeit of NADPH promotes a calcium/calmodulindependent protein kinase II (CaMKII) dependent inhibitory phosphorylation of caspase-2. Mutant caspase-2 resistant to CaMKII phosphorylation can circumvent this metabolism-dependent suppression of apoptosis, both in egg extracts and intact oocytes. These data, which are fully consistent with the reported requirement for caspase-2 in mouse oocyte apoptosis, link the operation of a specific metabolic pathway to the direct CaMKII-mediated regulation of caspase-2, thereby providing insight into the control of germ-cell life and death.
Results

G6P Inhibits Apoptosis in Xenopus Egg Extracts
If nutrient depletion contributed to apoptotic induction in Xenopus eggs and oocytes, we hypothesized that boosting glucose-utilizing metabolic pathways might forestall apoptosis in this system. Accordingly, we added G6P directly to the in vitro egg extract system and monitored cleavage of the model substrate, DEVDpNA, as a measure of caspase-3 activity. As shown in Figure 1A , the caspase-3 activation observed following incubation of the extract at room temperature was entirely suppressed by G6P addition. Note that G6P, which in oocytes is derived largely from gluconeogenesis or glycogenolysis, was used in these experiments rather than glucose due to the presence of very low hexokinase activity in these extracts (C.E.H. and L.K.N., unpublished data). We also found that G6P could inhibit apoptotic fragmentation of sperm nuclei added to egg extracts ( Figure 1B) . Consistent with the critical role for mitochondria in the induction of Xenopus egg apoptosis, the suppressive effects of G6P could be seen at the level of cytochrome c release ( Figure 1A, lower panel) . Moreover, the inhibitory effect of G6P on caspase activation and cytochrome c release could be overridden by addition of truncated Bid (tBid) to forcibly promote cytochrome c release ( Figure 1C ). These data indicate that G6P-containing extracts were still capable of activating caspases and that the observed block to apoptosis following G6P treatment occurred upstream of or at the level of the mitochondria.
Pentose-Phosphate-Pathway Intermediates Suppress Cell Death
In Xenopus eggs/oocytes, G6P is used for glycogen deposition or is metabolized through the pentose phosphate pathway. Indeed, the fate of radiolabeled G6P has been followed in amphibian oocytes, and little is metabolized by glycolysis (Dworkin and Dworkin-Rastl, 1989) . Consistent with this, we found that glycolytic intermediates, including glyceraldehyde-3-phosphate and pyruvate, had no effect on caspase-3 activation in egg extracts ( Figure 1D ). In contrast, 6-phosphogluconate, a pentose-phosphate-pathway intermediate, could mirror the ability of G6P to inhibit apoptosis ( Figure 1E ). These data suggested that some feature of pentosephosphate-pathway operation could suppress apoptosis. A key metabolic by-product of the pentose phosphate pathway is NADPH, produced when G6P is metabolized to 6-phosphogluconolactone and 6-phos-phogluconate is converted to ribulose-5-phosphate. Hypothesizing that production of NADPH might be the relevant consequence of G6P addition for apoptotic inhibition, we sought to generate NADPH using an alternative route and to examine the effects of direct NADPH addition to extracts. Addition of malate, which promotes NADPH production in concert with malic enzyme, potently inhibited mitochondrial cytochrome c release and caspase activation in the egg extract (Figure 1F) . Moreover, despite its relative instability in solution, NADPH could markedly suppress caspase activation ( Figure 1E ). These data suggest that G6P flux through the pentose phosphate pathway, leading to NADPH production, can potently suppress egg extract apoptosis. Although NADPH can act as a reducing agent, we do not believe that it is this feature of NADPH function that is responsible for apoptotic suppression as neither the SOD mimetic MnTBAP, the electron scavenger NAC, nor other reducing agents (TEMPO or reduced glutathione) could suppress extract apoptosis ( Figure 1G and data not shown).
Pentose-Phosphate-Pathway Inhibition Induces Apoptosis in Egg Extracts and Oocytes
Since hyperstimulation of the pentose phosphate pathway or NADPH addition inhibited caspase activation, we speculated that inhibition of the endogenous pentose phosphate pathway in egg extracts should accelerate apoptosis, particularly if the spontaneous extract apoptosis relied upon nutrient depletion during incubation. To test this, we treated extracts with the G6P dehydrogenase inhibitor, dehydroisoandrosterone (DHEA), to prevent entry of endogenous G6P into the pentose phosphate pathway (Schwartz and Pashko, 2004 ). This treatment accelerated apoptosis, largely eliminating the lag normally seen before caspase activation, as would be expected if pentose-phosphate-pathway function were important for extract "survival" ( Figure  2A ). We also examined extracts to determine whether endogenous G6P was depleted over time upon incubation. For this purpose, extracts were incubated at room temperature and assayed for caspase activation ( Figure  2B , top panel). Aliquots of extract withdrawn at the start of the incubation (0 hr) or just prior to caspase activation (2 hr) were incubated with a vast excess of G6P dehydrogenase and NADP and assayed over time for generation of NADPH, which, under these circumstances, depended solely on the available G6P. As shown in Figure 2B (middle panel), G6P levels (as measured by the rate of NADPH generation) dropped substantially within the 2 hr of incubation. Note also that NADPH generation remained high in extracts supplemented with excess G6P ( Figure 2B , lower panel).
We wished to extend these observations to whole oocytes to determine if the pentose phosphate pathway was important for suppressing death in these intact cells. For this, we developed a visual assay for oocyte death. Normally, oocytes contain a light-colored vegetal half and a dark, uniformly pigmented animal half. When induced to undergo maturation with progesterone, oocytes exhibit a white spot resulting from nuclear-envelope breakdown and clearance of surrounding pigment granules. We noted that a similar but considerably larger white spot appeared at the animal poles of oocytes injected with cytochrome c to induce caspase activation (C. Holley, personal communication). These oocytes did not exhibit elevated Cdc2/ cyclin kinase activity characteristic of maturing oocytes but rather showed high levels of caspase-3 activity (data not shown). Morphological events of apoptosis have been observed in oocytes by others, both in Xenopus and in other species ( ). Interestingly, we had observed that oocytes taken freshly out of a virgin female frog are remarkably refractory to apoptosis. With the idea that this resistance might stem from continual functioning of the pentose phosphate pathway, we soaked fresh oocytes in a DHEA-containing solution and monitored the appearance of large white spots at the animal poles. As shown in the micrographs in Figure 2C and the graph in Figure 2D , 200 M DHEA rapidly killed oocytes, while control treated oocytes remained healthy. These data were corroborated in experiments where cytochrome c was released from mitochondria in DHEA-treated but not control oocytes ( Figure 2E ). Importantly, this acceleration of oocyte death occurred at even lower doses of DHEA (100 M) and could be reversed by simultaneous treatment with the cell permeant D-methylmalate, which would be expected to promote NADPH generation within oocytes ( Figure 2F ). These data demonstrate that pentosephosphate-pathway inhibition promotes rapid oocyte death, suggesting that this pathway is normally critical for oocyte viability.
Caspase-2 Is a Target of NADPH-Mediated Apoptotic Inhibition
Since G6P (or NADPH) could inhibit apoptosis, we wished to identify the target of this inhibition. As mentioned above, genetic analyses in mice had implicated caspase-2 as an important constituent of oocyte apoptotic pathways (Bergeron et al., 1998) . To determine if caspase-2 was affected by G6P, we first examined processing of radiolabeled caspase-2 during spontaneous apoptosis. As shown in Figure 3A , addition of G6P, pentose-phosphate-pathway intermediates, malate, or NADPH all prevented caspase-2 processing, while glycolytic intermediates had no effect. Moreover, G6P inhibited endogenous caspase-2 processing, as detected by immunoblotting ( Figure 3H ). Caspase-2 processing in untreated extracts was inhibitable by the baculoviral caspase inhibitor p35 and the peptide inhibitor of caspase-2, VDVAD-fmk, but was not inhibited by BclxL, which prevented cytochrome c release and caspase-3 activation ( Figures 3B, 3C, and 3E) . Interestingly, treatment with p35 or VDVAD-fmk also inhibited cytochrome c release, consistent with the involvement of a caspase (potentially caspase-2) upstream of mitochondria in this system ( Figures 3D and 3E) . Moreover, neither caspase-2 processing nor cytochrome c release could be inhibited by the pancaspase inhibitor, z-VADfmk, consistent with previous reports that caspase-2 is markedly less sensitive to zVAD than other caspases (Garcia-Calvo et al., 1998) ( Figures 3B and 3D) . Thus, G6P could inhibit the z-VAD-insensitive, p35-and VDVAD-sensitive processing of caspase-2, most likely catalyzed by caspase-2 itself. Consistent with these observations, G6P blocked cleavage of the peptide substrate VDVAD-pNA ( Figure 3F ). In addition, VDVAD, which inhibited both caspase-2 processing and cytochrome c release in egg extracts, could block the DHEA-induced apoptosis of oocytes ( Figure 3G ). These data agree with the idea that caspase-2 is a critical inhibitory target of pentose-phosphate-pathway metabolites.
G6P and NADPH Prevent Activation of Caspase-2 by RAIDD
Caspase-2 is activated by oligomerization through binding of its CARD to adaptors (Duan and Dixit, 1997). Although our data suggested that G6P and NADPH could inhibit caspase-2, it was not clear that this inhibition was exerted at the level of caspase-2 rather than indirectly through inhibition of an upstream signaling component. To address this, we wished to promote direct caspase-2 oligomerization and determine if this, too, could be inhibited by G6P. The adaptor RAIDD binds to the caspase-2 CARD and has been implicated in caspase-2 activation in several settings. We have found that GST-RAIDD bound to glutathione Sepharose can, upon addition to egg extracts, directly promote caspase-2 processing ( Figure 4A ). Even this caspase-2 autoprocessing was inhibited by G6P or NADPH, suggesting that NADPH can interfere with direct RAIDDinduced caspase-2 activation ( Figure 4A ). Moreover, G6P or NADPH decreased the total amount of caspase-2 that could be retrieved from extracts in association with Sepharose-RAIDD, suggesting that these metabolites could interfere with adaptor-caspase-2 complex formation ( Figure 4B ). Similar results were obtained using in vitro-translated human caspase-2, whose processing was also inhibited by G6P and VDVAD in the egg extract ( Figures 4C-4E ). These data suggest that metabolic inhibition of caspase-2 can be exerted directly at the level of oligomerization/activation.
G6P and NADPH Promote Caspase-2 Phosphorylation by CaMKII
Since G6P and NADPH blocked activation of caspase-2 by RAIDD, we suspected that either these proteins were posttranslationally modified to prevent their interaction or a CARD binding inhibitor was recruited in the presence of G6P. Experiments to detect proteins bound to either GST-RAIDD or the GST-caspase-2 prodomain did not reveal any potential inhibitors bound only in the presence of G6P (data not shown). Therefore, we speculated that the CARD-containing regions of these proteins might be posttranslationally modified. Thus, we looked to see whether GST-RAIDD or the GSTcaspase-2 prodomain was phosphorylated in G6P-treated extracts. Although we saw no evidence of RAIDD phosphorylation, G6P addition greatly stimulated phosphorylation of the caspase-2 prodomain, derived from either human or Xenopus caspase-2 ( Figure 5A and data  not shown) . The caspase-9 prodomain was not phosphorylated under these conditions ( Figure 5A ). Note that prolonged exposure of kinase-assay gels revealed basal phosphorylation of the caspase-2 prodomain in untreated extracts, but this was markedly stimulated by G6P (Figures 5A and 5B) . Moreover, endogenous procaspase-2 immunoprecipitated from egg extracts incubated with [γ-32 P]ATP was also phosphorylated, and this phosphorylation was stimulated by G6P ( Figure 5C ).
To identify the kinase (or kinases) phosphorylating the caspase-2 prodomain, we repeated the experiment in Figure 5B in the presence of a battery of kinase inhibitors. Inhibition of several kinases previously implicated in apoptotic regulation, including PKC, PKA, AKT, and MEK, had no effect on G6P-stimulated caspase-2 phosphorylation ( Figure 5D and data not shown). However, UCN-01 blocked phosphorylation of the caspase-2 prodomain ( Figure 5D ). Although UCN-01 is a broadspectrum kinase inhibitor, it has been used extensively in Xenopus egg extracts to inhibit both Chk1 and CaMKII (Graves et al., 2000; Hutchins et al., 2003) . The inability of caffeine, an inhibitor of Chk1-activating kinases, to override G6P suggested Chk1 might not play a role in this pathway ( Figure 5D ). Indeed, Chk1 immunodepletion produced no loss of G6P-stimulated prodomain phosphorylation ( Figure 5E ). Conversely, treatment of egg extracts with the general CaMK inhibitor, KN93, led to a substantial loss of G6P-stimulated caspase-2 phosphorylation ( Figure 5F ). Moreover, depletion of extracts using calmodulin Sepharose or treatment of extracts with the calmodulin inhibitors W7 or W13 markedly diminished G6P-triggered phosphorylation of caspase-2, consistent with the involvement of a calmodulin binding protein in this pathway (Figures 5G and 6D) . Moreover, excess calcium stimulated and EGTA inhibited phosphorylation of the caspase-2 prodomain, consistent with the involvement of a calcium-regulated kinase ( Figure 6C ).
To determine if CaMKs could phosphorylate the caspase-2 prodomain, we incubated the GST prodomain in vitro with [γ-32 P]ATP and either CaMKI, CaMKII, or CaMKIV. Only CaMKII could phosphorylate the recombinant caspase-2 prodomain (CaMKII could also phosphorylate the human caspase-2 prodomain), although all kinases were active against their model peptide sub- strates ( Figure 6A, right) . More importantly, two specific peptide inhibitors of CaMKII (Ca 2+ /calmodulin kinase II inhibitor 281-309 and autocamtide-2-related inhibitory peptide) could prevent G6P-induced phosphorylation of both a model CaMKII substrate and the caspase-2 prodomain (Figures 6B-6D) . These data strongly suggest that CaMKII mediates G6P-stimulated caspase-2 phosphorylation.
Abrogation of Caspase-2 Phosphorylation Prevents Metabolite-Mediated Survival
Given the involvement of CaMKII in caspase-2 phosphorylation, we scanned the caspase-2 prodomain for sequence motifs characteristic of CaMK phosphorylation sites and identified Ser73 and Ser135 as candidate sites; these were individually changed to Ala. When we assayed these mutants in egg extracts, we found that both G6P and NADPH-stimulated prodomain phosphorylation were abrogated by the S135A mutation but were unaffected by Ser73 alteration ( Figure 7A ). Ser135 mutation also prevented in vitro phosphorylation by CaMKII ( Figure 6A ). To determine if this site was critical for metabolic suppression of caspase-2, we produced mRNA and in vitro-translated proteins for full-length wild-type, S135A, and S73A caspase-2. As shown in Figure 7B , the S135A protein was processed even in the presence of G6P. More importantly, mutation of Ser135 to Ala not only overrode the G6P-mediated block to spontaneous caspase-3 activation in egg extracts but also overrode the inhibition of RAIDDinduced processing and binding to caspase-2 ( Figures  7C and 7D and data not shown) . Strikingly, the S135A mutant also induced apoptosis in oocytes ( Figure 7E ). Consistent with a role for CaMKII in suppressing caspase-2-mediated death of intact oocytes, prior injection of the CaMKII peptide inhibitor allowed efficient cell-death induction by subsequent injection of the wt procaspase-2 mRNA ( Figure 7F ). These data demonstrate that metabolic suppression of caspase-2 in eggs and oocytes is exerted through CaMKII-mediated phosphorylation of the caspase-2 prodomain.
Discussion
Although it has long been appreciated that oocytes die by apoptosis, the signaling pathways governing death (Bergeron et al., 1998) . We have found that stimulation of the pentose phosphate pathway, leading to NADPH generation, can restrain caspase-2 via the action of CaMKII, thereby promoting oocyte/egg survival.
Oocyte/Egg Metabolic Pathways and Apoptosis
Studies on metabolic flux in Xenopus oocytes have demonstrated that glycolysis is low in these cells and that the majority of carbon that could enter glycolytic pools is, instead, rapidly converted to glycogen (Dworkin and Dworkin-Rastl, 1989). However, this glycogen is not metabolized until after gastrulation and does not serve as an energy source to support early embryogenesis (Cohen, 1954; Jaeger, 1945) . Rather, it has been proposed that amino acids derived from yolk-protein breakdown can be partially oxidized to malate in mitochondria, which is then oxidized to oxaloacetate and converted to phosphoenolpyruvate to generate G6P (Dworkin and Dworkin-Rastl, 1989; Kovacevic and Morris, 1972; Maller, 1985; Reitzer et al., 1979). According to this scenario, yolk proteins serve as the source of energy for the oocyte and early embryo. Our observations suggest that maintenance of G6P levels from adequate yolk-protein stores can prevent death of oocytes and eggs. It is worth noting that the amount of G6P required to achieve full inhibition of apoptosis in egg extracts is quite high (i.e., greater than 2.5 mM). Consistent with previous measurements of radiolabeled G6P flux in amphibian oocytes, we believe that the vast majority of the added G6P is shunted directly into glycogen synthesis and that only a small amount is available to enter the pentose phosphate pathway (Dworkin and Dworkin-Rastl, 1989; Ureta et al., 2000) . Within the animal, such levels could be maintained as long as yolkprotein stores were continually feeding G6P production.
Because stimulation of pentose-phosphate-pathway metabolism, malate, or NADPH could substitute for G6P to inhibit apoptosis, our data suggest that it is NADPH generation that transmits the antiapoptotic signal. Addition of NADH or stimulation of NADH production did not have similar effects, pointing to the speci- Figures 1D and 3A and data not shown). Also consistent with the involvement of pentose-phosphate-pathway operation are our observations that inhibition of G6P dehydrogenase could accelerate caspase activation in both egg extracts and oocytes. Although the initiator of spontaneous death in the Xenopus egg system has not been previously identified, our data suggest that an active signaling system is engaged to keep these cells alive and that the default pathway, when key metabolites cannot be maintained, is cell death.
ficity of our results (
Although it is attractive to speculate that nutrient stockpiles serve as a timer for oocyte survival, changes in pentose-phosphate-pathway flux might also result from age-or hormone-related alterations in enzyme activities. Indeed, age-related decreases in G6P dehydrogenase activity have been observed in mouse oocytes, and it has been suggested that, even if such oocytes survive, they may develop poorly postfertilization (de Schepper et al., 1987).
Caspase-2 Is a Target for the Antiapoptotic Action of NADPH
A previous report that caspase-2 was required for oocyte apoptosis led us to investigate caspase-2 as a potential target of metabolic regulation (Bergeron et al., 1998) . In addition to our observation that caspase-2 processing was inhibited by G6P or NADPH, the fact that a caspase-2 mutant resistant to phosphorylation could override the effects of G6P in egg extracts as well as the natural resistance of intact oocytes to apoptosis strongly suggests that caspase-2 is an important target of metabolic survival pathways.
It is not clear how caspase-2 is activated in oocytes. However, based on the ability of RAIDD-mediated activation to be regulated by NADPH and G6P, we hypothesize that an endogenous adaptor protein binding to the caspase-2 prodomain promotes activation; phosphorylation of the prodomain could block access of the adaptor, preventing activation. Consistent with such a possibility, caspase-2 binding to GST-RAIDD was substantially reduced by G6P and NADPH addition.
CaMKII Phosphorylates and Inhibits Caspase-2
Based on calmodulin Sepharose depletion, kinase assays, and inhibitor studies, we conclude that CaMKII maintains caspase-2 phosphorylation in response to pentose-phosphate-pathway operation. Although this phosphorylation was stimulated by G6P, we note that basal phosphorylation could be observed upon longer exposure of kinase assays. We suggest that basal phosphorylation can keep caspase-2 suppressed and that dephosphorylation occurs prior to entry of extracts into apoptosis. Consistent with this, the GST-caspase-2 prodomain prephosphorylated with CaMKII loses its radioactive labeling immediately preceding caspase-3 activation in the extract (L.K.N. and S.S.M., unpublished data). We were able to maintain this phosphorylation through the simple provision of metabolites.
Although our data demonstrate that CaMKII activity is required for maintaining caspase-2 suppression in response to nutrients, it is not yet clear how NADPH levels are translated into sustained phosphorylation. It is possible that a caspase-2-directed phosphatase is regulated to antagonize constitutive CaMKII-mediated caspase-2 phosphorylation supported by ambient calcium levels in the egg/oocyte. However, the fact that CaMKII phosphorylation of model peptides (which we might not expect to be targeted for dephosphorylation by the same phosphatases as the prodomain) was increased following G6P/NADPH treatment suggests that these metabolites may increase CaMKII activation or activity. It is possible that a phosphatase controlling CaMKII activity (through regulation of the CaMKII-activating phosphorylation at Thr286 as observed in other settings) is regulated by NADPH (Blitzer et al., 1998) . It is not clear whether pathways regulating calcium storage or utilization may also be regulated by NADPH to control CaMKII activation. In any event, the spontaneous activation of the S135A mutant caspase-2 (even in cytosol lacking mitochondria; data not shown) demonstrates that maintenance of this phosphorylation is critical to keep eggs/oocytes alive. Because processing of the S135A mutant was slightly slower in the presence of G6P (see Figure 7B) , it may be that additional modes of caspase-2 regulation (or targets other than caspase-2) contribute to G6P-mediated apoptotic suppression. However, S135 is clearly a major target of this regulatory pathway. Moreover, because there is still a lag time until apoptosis in the presence of the S135A mutant, pathways in addition to the CaMKII-caspase-2 pathway may contribute to the normal suppression of apoptosis in oocytes/eggs. Although further experiments will be required to fill in the precise regulatory details, this work has revealed key elements of a previously unknown pathway linking oocyte metabolism to caspase-2 through the action of CaMKII. This work may help to explain why oocytes are lost through apoptosis as females age, thereby providing potential therapeutic targets for the maintenance of oocyte viability and fertility.
Experimental Procedures Preparation of Xenopus Oocytes and Extracts
Egg extracts were prepared as in Smythe and Newport (1991). Stage VI oocytes were prepared from ovaries manually excised from PMSG-primed frogs, digested with 2.8 units of liberase in OR-2 buffer (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 5 mM HEPES [pH 7.5]) for 1.5 hr at room temperature, washed extensively with OR-2 buffer, and stored in OR-2 buffer + 1% fetal bovine serum + 0.2% gentamicin at 18°C.
Caspase Assays and Metabolite Addition
To measure caspase activity, 3 l extract aliquots were incubated with 90 l DEVDase buffer (50 mM HEPES [pH 7.5], 100 mM NaCl, 0.1% CHAPS, 10 mM DTT, 1 mM EDTA, 10% glycerol) and the substrate Ac-DEVD-pNA (200 M) at 37°C for 30-60 min. Absorbance was measured at 405 nm. For some experiments, extracts were treated with G6P (2.5-10 mM), NADPH (5-10 mM), or other metabolites (all 10 mM). Other reagents were used at 100 M (zVAD), 500 nM (Bcl-xL), and 25 nM (tBid). 
Xenopus Oocyte Apoptosis Assays
